Abstract
Monoamine oxidase (MAO, EC 1.4.3.4.) is an enzyme widely distributed in mammalian tissues and especially in the brain. Two major forms, MAO A and MAO B seem to exist on the basis of substrate specificity and existence of reversible and irreversible inhibitors. MAO A preferentially deaminates biogenic amines such as 5-hydroxy-tryptamine (5-HT), adrenaline and noradrenaline and is selectively inhibited by clorgyline, whereas MAO B oxidises the microamine phenylethylamine (PEA) and is inhibited by deprenyl (Neff et al., 1976; Fowler et al., 1978; Gerardy, 1980; Houslay et al., 1976).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Backle, Y.S. and Youdim, M.B.H. (1975). J. Physiol. (London), 248, 1, 111–115.
Barger, G. and Dale, H.H. (1910)., J. Physiol., 41, 19–59.
Baum, T. and Bennett, D.R. (1963). Arch. int. Pharmacodyn., 146, No 1–2, 280–284.
Boismare, F., Derrey, D., Audisio, M. and Brocherion, J. (1974). Therapie, 29, 435–446.
Boulton, A.A. (1978). Life Sci., 23, 659–672.
Boulton, A.A. (1979). in Physiological and Pharmacological Biochemistry, Vol. 26 (ed. K.F. Tipton), University Park Press, Baltimore., pp 179–206.
Braestrup, C., Andersen, H. and Randrup, A. (1975). Eur. J. Pharmacol., 34, 181–187.
Burkard, W.P. and Kettler, R. (1977). Biochem. Pharmacol., 26, 1303–1306.
Burtin, C., Lebel, B. and Soubrane, C. (1977). Ag. Actions, 7, No 1, 107.
Chanoine, F., Strolin Benedetti, M., Ancher, J.F. and Dostert, P. submitted Arzneim.-Forsch.
Cohen, G., MacNamee, D. and Dembiec, D. (1975). Biochem. Pharmacol. 24, 3.13–316.
Curda, D., Hrdlicka, J. and Procingerova, A. (1972). Sb. Vys. Sk. Chem.-Technol. Praze, Potraviny, E 34, 65–84.
Dembiec, D., MacNamee, D. and Cohen, G. (1976). J. Pharmac. Exp. Therap., 197, 332–339.
Dial, J. and Clarke, D.E. (1977). Res. Commun. Chem. Pathol. Pharmacol., 17, Nol, 145–156.
Diehl, E., Najm, S., Wolff, R.E. and Ehrhardt, J.D. (1976). J. Pharmacol., 7, 563–575.
Donnelly, C.H. and Murphy, D. (1977). Biochem. Pharmacol., 26, 853–858.
Drawert, F. (1965). Vitis, 5, 2, 127–130.
Durden, D.A., Philips, S.R. and Boulton, A.A. (1976). Biochem. Pharmacol., 25, 858–859.
Edwards, D.J. and Venetti, M.C. (1977). Neurosci. Abstr., 3, 313.
Edwards, D.J. (1978). Life Sci., 23, 1201–1208.
Elsworth, J.D., Glover, V. and Sandler, M. (1980). Psychopharmacology., 69, No3, 287–290.
Fowler, C.J., Callingham, B.A., Mantle, T.J. and Tipton, K.F. (1978). Biochem. Pharmacol., 27, 97–101.
Fowler, C.J., Ekstedt, B., Egashira, T., Kinemuchi, H. and Oreland, L. (1979). Biochem. Pharmacol., 28, 3063–3068.
Fowler, J.S., Gallagher, B.M., MacGregor, R.R. and Wolf, A.P. (1976). J. Pharmacol. Exp. Therap., 198, 1, 133–145.
Gallagher., B.M., Fowler, J.S., MacGregor, R.R. and Wolf, A.P. (1977). Biochem. Pharmacol., 26, 1917–1922.
Gérardy, J. (1980). Pharm. Belg., 35, 2, 133–142.
Golovnya, R.V., Mironov, G.A. and Zhuraveleva, I.L. (1967). Zh. Anal. Khim., 22(4), 612–617.
Hough, L.B. and Domino, E.F. (1979). J. Pharmacol. Exp. Therap. 208, 3, 422–428.
Houslay, M.D., Garrett, N.J. and Tipton, K.F. (1974). Biochem. Pharmacol., 23, 1937–1944.
Houslay, M.D. and Tipton, K.F. (1976). Life Sci., 19, 467–478.
Hrdlicka. J. and Janicek, G. (1964). Nature, 204, (4964), 1201.
Innes, I.R. and Nickerson, M. (1975). in The Pharmacological Basis of Therapeutics, 5th ed. (eds. L.S. Goodman and A. Gilman) Macmillan Publishing Co., N.Y., pp L77–513.
Irvine, W.J. and Saxby, M.J. (1969). Phytochemistry, 8 (2), 473–476.
Jalfre, M., Bucher, B., Coston, A., Mocquet, G. and Porsolt, R.D. (1980). Abstracts of the 12th CINP Congress, Göteborg, No 316, Pergamon Press.
Johnston., J.P. (1968). Biochem. Pharmacol., 17, 1285–1297.
Kan, J.P. and Strolin Benedetti, M. (1980). Life Sci., 26, 2165–2171.
Kan, J.P. and Strolin Benedetti, M. (1981). J. Neurochem., in press.
Kinemuchi, H., Wakui, Y., Toyoshima, Y., Hayashi, N. and Kamijo, K. (1979). in Monoamine oxidase: structure, function and alte-red functions, (eds. T.P. Singer, R.W. von Korff and D.L. Murphy) Academic Press. pp 205–212.
Klemm, H.P. and Baumgarten, H.G. (1978). Ann. N.Y. Acad. Sci., 305, 36–56.
Knight, R. I. and Smith, I.R. (1978). Br. J. Pharmacol., 64, 404P.
Kung, H.C. and Wilson, A.G.E. (1979). Life Sci., 24, 425–432.
Lebsack, M.E., Petersen, D.R. and Collins, A.C. (1977). Biochem. Pharmacol., 26, 1151–1154.
Lehninger, A.L. (1975). in Biochimica, (ed. Zanchelli), Chapter 19
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) J. Biol. Chem., 193, 265–275.
Lyles, G.A. (1978). Life Sci., 23, 223–230.
Mantle, T.J., Tipton, K.F. and Garrett, N.J. (1976). Biochem. Pharmacol., 25, 2073–2077.
Mongar., J.L. and Schild, H.O. (1953). Br. J. Pharmacol., 8, 103109.
Murphy, D.L., Lipper, S., Slater, S. and Shiling, D. (1979). Psychopharmacology, 62, 129–132.
Nakanishi, S., Yamazaki, H. Nishiguchi, K. and Saladin R. (1980). Arch. Toxicol., 46, 241–248.
Neff, N.H. and Yang, H.-Y.T. (1974). Life Sci., 14, 2061–2074.
Neff, N.H. and Fuentes, J.A. (1976). in Monoamine oxidase and its inhibition, Ciba Foundation Symposium 39, Elsevier, Excerpta Medica, pp 163–179.
Ney, K.H. and Wirotama, I.P.G. (1971a). Z. Lebensm.-Unters.-Forsch. 146. (6), 337–343.
Ney, K.H. and Wirotama, I.P.G. (1971b). Z. Lebensm.-Unters.-Forsch. 146 (6), 343–344.
Nonaka, J., Le Thi Minh, D. and Koizumi, C. (1975). J. Tokyo Univ. Fish., 62 (1). 1–10.
Pailer, M., Huebsch, J. and Kuhn, H. (1966). Monatsh. Chem., 97, 5, 1448–1451.
Peers, E.M., Lyles, G.A. and Callingham, B.A. (1980). Biochem. Pharmacol., 29, 1097–1102.
Philips, S.R. and Boulton., A.A. (1979). J. Neurochem., 33, 159–167.
Pirisino, R., Ciottoli, C.B., Buffoni, F., Anselmi, B. and Curradi, C. (1979). Br. J. Clin. Pharmacol., 7. No6. 595–598.
Polonovski, J. (1967). in Traité de Biochimie Génerale, III, (ed. Masson et Cie, Paris), pp 254–271.
Pourrias, B., Sergant, M. and Raynaud, G. (1969). Therapie, 24, 451–466.
Prozialeck, W.C. and Vogel, W.H. (1978). Life Sci., 22, No 7, 561–569.
Reynolds, G.P., Elsworth, J.D., Blau, K., Sandler, M., Lees, A.J. and Stern, G.M. (1978). Br. J. Clin. Pharmacol., 6, No 6, 542–544.
Riceberg, L.J. and Vunakis, H.van (1978). Abstr. Papers, Am. Chem. Soc. 176 Meet. BIOL. 133.
Sanders, B., Collins, A.C., Petersen, D.R. and Fish, B.S. (1977). Pharmacology Biochemistry and Behavior, 6, 319–324.
Shirota, F.N., DeMaster, E.G., Elberling, J.A. and Nagasawa, H.T. (1980). J. Med. Chem., 23, 669–673.
Sourkes, T.L. (1972). Pharmacological Keviews, 24, 2, 349–359.
Sourkes, T.L. and Missala, K. (1976) in Monoamine oxidase and its inhibition, Ciba Foundation Symposium 39, Elsevier, Excerpta Medica, pp 83–103.
Sourkes,. T.L. and Missala, K. (1977a). Can. J. Biochem., 55, 1, 56–59.
Sourkes, T.L., Missala, K., Bastomsky, C.H. and Fang, T.Y.(1977b) Can. J. Biochem., 55, 8, 789–795.
Strolin Benedetti, M., an, J.P. and Keane, P.E. (1979) in Monoamine oxidase: Structure, function and altered functions, (eds. T.P. Singer, R.W. von Korff and D.L. Murphy) Academic Press, pp 335–340.
Strolin Benedetti, M., Ancher, J.F. and Sontag, N. (1980). Experientia, 36, 818–820.
Suzuki, O., Katsumata, Y. and Oya, M. (1979a). Biochem. Pharmacol. 28, 2327–2332.
Suzuki., O., Hattori, H., Katsumata, Y. and Oya, M. (1979b). Life Sci., 25, 1231–1236.
Suzuki, O., Oya, M. and Katsumata, Y. (1979c). Biochem. Pharmacol., 28, 2682–2684.
Suzuki, O., Matsumoto, T., Oya, M. and Katsumata, Y. (1979d). Experientia, 35, 1283–1284.
Suzuki, O., Katsumata, Y. and Oya, M. (1979e). Life Sci., 24, 2227–2230.
Suzuki, O., Katsumata, Y. and Oya, M. (1979f) in Monoamine oxidase: structure, function and altered functions, (eds. T.P. Singer., R.W. von Korff and D.L. Murphy) Academic Press, pp 197–204.
Suzuki, O., Oya, M. and Katsumata, Y. (1980). Biochem. Pharmacol. 29, 2663–2667.
Symes, A.L., Missala, K. and Sourkes, T.L. (1971). Science, 174, 153–155.
Swanson, E.E. and Chen, K.K. (1946). J. Pharmacol. Exp. Therap. 88, 10–13.
Tainter, M.L. (1933). Arch. int. Pharmacodyn., 46, 192–232.
Tierney, D.F. (1974). Annu. Rev. Physiol., 36, 209–231.
Tuomisto, J., Walaszek, L.J. and Smissman, E.E. (1974). J. Pharm. Sci., 63, (1), 15–18.
Waldmeier, P.C., Feldtrauer, J.J. and Maitre, L. (1977a). Arch. Pharmac., 297, suppl. 2, R57.
Waldmeier, P.C., Feldtrauer, J.J. and Maître, L. (1977b). J. Neurochem., 29. 785–790.
Wechsler, A.S., Epstein, S.E. and Glick, G. (1969). J. Pharmacol. Exp. Therap., 170, 62–71.
Yu, P.H. and Boulton, A.A. (1980). J. Neurochem., 35. 255–257.
Zilletti, L., Franchi Michell, S. and Rosselli, P. (1978). Ag. Actions, 8, No 5, 462–469.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1981 The Contributors
About this chapter
Cite this chapter
Benedetti, M.S., Sontag, N., Boucher, T., Kan, JP. (1981). Aliphatic amines as MAO substrates in the rat: the effect of selective inhibitors on the deamination of n-pentylamine. In: Usdin, E., Weiner, N., Youdim, M.B.H. (eds) Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06276-8_58
Download citation
DOI: https://doi.org/10.1007/978-1-349-06276-8_58
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06278-2
Online ISBN: 978-1-349-06276-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)